Showing 1 - 10 of 290
Objectives: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically assessing the impact of regulation on pharmaceutical...
Persistent link: https://www.econbiz.de/10010526909
Persistent link: https://www.econbiz.de/10012197768
Persistent link: https://www.econbiz.de/10012242700
Persistent link: https://www.econbiz.de/10011708133
To meet the requirements of global competition, the European Union (EU) places particular emphasis on the development of knowledge‑intensive, innovative industries. The pharmaceutical industry, as a high‑tech manufacturing subsection, has a long tradition in Europe. However, the distribution...
Persistent link: https://www.econbiz.de/10012665037
Persistent link: https://www.econbiz.de/10012437079
Persistent link: https://www.econbiz.de/10013163669
Chapter 1: The Chinese healthcare and pharmaceutical market: Ignore at your own peril -- Chapter 2: China regulatory and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma: Explosive growth in a thriving ecosystem -- Chapter 4:...
Persistent link: https://www.econbiz.de/10014519028
Persistent link: https://www.econbiz.de/10009640861